7:30 AM

Registration Desk Opens

Coffee and breakfast will be available from 8:00 - 9:00 AM

9:00 AM 

Welcome and Opening Remarks

Opening reflections on the goals of the meeting, the evolving landscape of dementia prevention research, and OMNI ADRD’s role in advancing next-generation measurement infrastructure.

9:00 – 9:10 AM | Welcome and Agenda

9:10 – 9:20 AM | Remarks from NIA

Dr. Lisbeth Nielsen, Director, NIA Behavioral and Social Research

Dr. Jennie Larkin, Acting Director, NIA Division of Neuroscience

9:20 – 9:30 AM | Framing and Introductions

Dr. Kristina McLinden, NIA Program Director and OMNI ADRD Project Scientist

Dr. Luke Stoeckel, NIA Program Director and OMNI ADRD Project Scientist

Dr. Todd Horowitz, NIA Program Director

9:30 AM 

SESSION 1: Dementia Prevention: Implications for OMNI ADRD Priorities, Capabilities, and Value in Supporting Primary Prevention Trials

This session will examine how the shift toward dementia prevention changes the scientific and operational requirements for cognitive and functional measurement, and how OMNI ADRD can support prevention-oriented studies and trials.

9:30 – 9:35 AM | Introduction

9:35 – 10:00 AM | Plenary Presentation - Dr. David Conroy, University of Michigan

10:00 – 10:25 AM | Plenary Presentation - Dr. Jessica Langbaum, Banner Health

10:25 – 10:45 AM | Panel Discussion

Dr. David Conroy, University of Michigan

Dr. Jessica Langbaum, Banner Health

Dr. Kate Papp, Harvard University, The Brigham and Women's Hospital

Dr. Lesley Ross, Clemson University

Moderated by Dr. Kristina McLinden, NIA Program Director and OMNI ADRD Project Scientist  

10:45 AM 

Break

Coffee will be provided.

11:00 AM 

SESSION 2: Functional Measures of Cognition

This session explores how everyday functioning, decision-making, and passive monitoring approaches may complement traditional cognitive assessment and provide new insights into early change detection. Brief updates from working groups will be provided.

11:00 – 11:05 AM | Introduction

11:05 – 11:20 AM | Presentation: Passive and Continuous Monitoring, Dr. Ganesh Babulal, Mayo Clinic

11:20 – 11:35 AM | Presentation: Financial Decision Making, Dr. Duke Han, University of Southern California

11:35 – 11:50 AM | Panel Discussion

Dr. Ganesh Babulal, Mayo Clinic

Dr. Duke Han, University of Southern California 

Dr. Nelson Roque, Penn State

Dr. Andy Saykin, Indiana University 

Moderated by Dr. Luke Stoeckel, NIA Program Director and OMNI ADRD Project Scientist  

11:50 AM 

Lunch

Lunch will be provided in The Terrace (2nd floor)

1:00 PM 

SESSION 3: OMNI Working Groups: Progress, Challenges, and Priorities

Brief working group updates highlighting progress, emerging scientific and implementation challenges, and areas where broader network input is needed.

1:00 – 1:05 PM | Introduction

1:05 – 2:30 PM | Working Group Reports

Dr. Louisa Thompson, Brown University — Digital Measures Evaluation Framework

Drs. Andrea Cataldo, Harvard University, McLean Hospital & Jason Hassenstab, Washington University in St. Louis —Psychometric Change

Dr. Oshadi Jayakody, Albert Einstein College of Medicine — Barriers to Implementation for Trainees

Dr. Aaron Seitz, Northeastern University — Sensory-Motor Working Group

Dr. Elizabeth Muñoz, University of Texas at Austin — Strategies for Community Engagement

Dr. Laura Rabin, Brooklyn College, CUNY—Subjective Cognition

2:30 PM 

Introduction to Session 4: Breakout Discussions

Break

Coffee will be provided.

2:45 PM 

SESSION 4: Breakout Discussions

These sessions are intended to generate focused discussion around high-priority scientific, methodological, and implementation questions relevant to OMNI ADRD's next phase of development. Discussions should identify opportunities, challenges, and actionable priorities for the network.

2:45 – 3:30 PM | Round 1 Topics

Defining and Quantifying Cognitive Change 
Leads: Drs. Joey Mukherjee, University of Washington and Sy-Miin Chow, Penn State

OMNI ADRD Measures Evaluation Framework: Criteria, Tensions, and Open Questions
Leads: Drs. Louisa Thompson, Brown University and Aaron Seitz, Northeastern University

What Do Prevention Trials Need from OMNI ADRD? Priorities, Barriers, and Partnership Opportunities
Leads: Drs. Jessica Langbaum, Banner Health and David Conroy, University of Michigan

Building Sustainable Open Science Across OMNI: What is Open, For Whom, and At What Cost?
Leads: Drs. Laura Germine, Albert Einstein College of Medicine and Luke Stoeckel, NIA Program Director and OMNI ADRD Project Scientist

3:30 – 4:15 PM | Round 2 Topics

Community Engagement and Applied Validity: Real-World Populations, Accessibility, and Implementation
Leads: Drs. Liz Muñoz, University of Texas at Austin and Alyssa Gamaldo, Clemson University

Training the Next Generation of Cognitive Change Assessment Researchers: What Can OMNI ADRD Offer Trainees and Early-Career Investigators?
Leads: Drs. Oshadi Jayakody, Albert Einstein College of Medicine and Laura Germine, Albert Einstein College of Medicine

Adapting Evaluation for Continuous, Real-World Signals: Applying the OMNI ADRD Measures Evaluation Framework to Passive and Sensor-Based Data
Leads: Drs. Ganesh Babulal, Mayo Clinic and Nelson Roque, Penn State

The Critical Role of Everyday Experience and Subjective Cognition in AD/ADRD Prevention Research
Leads: Drs. Laura Rabin, Brooklyn College, CUNY and David Almeida, Penn State

4:15 PM 

SESSION 5: Synthesis and Next-Year Priorities

Brief working group updates highlighting progress, emerging scientific and implementation challenges, and areas where broader network input is needed.

4:15 – 4:55 PM | Breakout Report-Outs and Network Discussion

4:55 – 5:00 PM | Closing Reflections

5:00 PM 

Adjourn